Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

1J2N

Solution structure of CPI-17(22-120) T38D

Summary for 1J2N
Entry DOI10.2210/pdb1j2n/pdb
Related1J2M
Descriptor17-kDa PKC-potentiated inhibitory protein of PP1 (1 entity in total)
Functional Keywordshelix bundle, protein binding
Biological sourceSus scrofa (pig)
Cellular locationCytoplasm: O18734
Total number of polymer chains1
Total formula weight11560.06
Authors
Ohki, S.,Eto, M.,Shimizu, M.,Takada, R.,Brautigan, D.L.,Kainosho, M. (deposition date: 2003-01-07, release date: 2003-06-17, Last modification date: 2023-12-27)
Primary citationOhki, S.,Eto, M.,Shimizu, M.,Takada, R.,Brautigan, D.L.,Kainosho, M.
Distinctive Solution Conformation of Phosphatase Inhibitor CPI-17 Substituted with Aspartate at the Phosphorylation-site Threonine Residue
J.Mol.Biol., 326:1539-1547, 2003
Cited by
PubMed Abstract: We present solution NMR structures for wild-type and mutated forms of CPI-17, a phosphoinhibitor for protein phosphatase 1. Phosphorylation of Thr38 of CPI-17 produces a >1000-fold increase in inhibitory potency for myosin phosphatase. We compared the 1H-15N heteronuclear single quantum coherence spectroscopy (HSQC) chemical shifts of wild-type CPI-17, partially phosphorylated CPI-17 and CPI-17 with Thr38 replaced with Asp to introduce a negative charge. There was a switch in the protein conformation due to either Asp substitution or phosphorylation, so we determined the solution NMR structure of the CPI-17 T38D mutant as a model for the active (phospho-) conformation. The structures reveal a molecular switch in conformation that involves the rotation of two of the four helices in the four helix bundle. Despite this conformational switch, there was little increase in the inhibitory potency with T38D. We propose that for this inhibitor, a negative charge at residue 38 is sufficient to trigger an active conformation, but a phosphoryl group is required for full inhibitory potency against protein phosphatase-1.
PubMed: 12595264
DOI: 10.1016/S0022-2836(03)00048-2
PDB entries with the same primary citation
Experimental method
SOLUTION NMR
Structure validation

230444

PDB entries from 2025-01-22

PDB statisticsPDBj update infoContact PDBjnumon